High-throughput genomic profiling of tumor-infiltrating leukocytes

Slides:



Advertisements
Similar presentations
Microarray statistical validation and functional annotation
Advertisements

Yinyin Yuan and Chang-Tsun Li Computer Science Department
Original Figures for "Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring"
Charlie Whittaker – BIG meeting 12/3/14
Lessons Learned from Measuring Cell Response by Quantitative Automated Microscopy FDA Workshop, Potency Measurements for Cellular and Gene Therapy Products,
Part II: Discriminative Margin Clustering Joint work with: Rob Tibshirani, Dept of Statistics Patrick O. Brown, School of Medicine Stanford University.
Fuzzy K means.
Introduction to molecular networks Sushmita Roy BMI/CS 576 Nov 6 th, 2014.
 MicroRNAs (miRNAs) are a class of small RNA molecules, about ~21 nucleotide (nt) long.  MicroRNA are small non coding RNAs (ncRNAs) that regulate.
The Broad Institute of MIT and Harvard Classification / Prediction.
Unraveling condition specific gene transcriptional regulatory networks in Saccharomyces cerevisiae Speaker: Chunhui Cai.
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks From Nature Medicine 7(6) 2001 By Javed.
Decoding the Network Footprint of Diseases With increasing availability of data, there is significant activity directed towards correlating genomic, proteomic,
Computational Approaches for Biomarker Discovery SubbaLakshmiswetha Patchamatla.
Cluster validation Integration ICES Bioinformatics.
Pan-cancer analysis of prognostic genes Jordan Anaya Omnes Res, In this study I have used publicly available clinical and.
PLANT BIOTECHNOLOGY & GENETIC ENGINEERING (3 CREDIT HOURS) LECTURE 13 ANALYSIS OF THE TRANSCRIPTOME.
Computational Biology Group. Class prediction of tumor samples Supervised Clustering Detection of Subgroups in a Class.
Multiplatform Analysis of 12 Cancer Types Reveals Molecular Classification within and across Tissues of Origin Hoadley, KA et al. Cell 158(4):
Identification of Cancer Stem Cells using Flow Cytometry Analysis تعيين الخلايا الجذعية السرطانية باستخدام تحليل التدفق الخلوي Dr. Ayat Al-Ghafari Biochemistry.
I. Statistical Methods for Genome-Enabled Prediction of Complex Traits OUTLINE THE CHALLENGES OF PREDICTING COMPLEX TRAITS ORDINARY LEAST SQUARES (OLS)
Data statistics and transformation revision Michael J. Watts
Think like an experimentalist 10/11/10. Melissa, you’re a modeler! And I do “systems biology”. So model this data for me!!
Big data classification using neural network
Regression Models for Linkage: Merlin Regress
miRNA-targets cross-talks: key players in glioblastoma multiforme
Semi-Supervised Clustering
1. SELECTION OF THE KEY GENE SET 2. BIOLOGICAL NETWORK SELECTION
KnowEnG: A SCALABLE KNOWLEDGE ENGINE FOR LARGE SCALE GENOMIC DATA
Reduced number of peripheral natural killer cells in schizophrenia but not in bipolar disorder – a computational deconvolution study Paweł Karpiński1,
Gene expression.
Intervista a Federico Cappuzzo
Research in Computational Molecular Biology , Vol (2008)
Global Transcriptional Dysregulation in Breast Cancer
Machine Learning Basics
Dept of Biomedical Informatics University of Pittsburgh
Hierarchical clustering approaches for high-throughput data
Low Dimensionality in Gene Expression Data Enables the Accurate Extraction of Transcriptional Programs from Shallow Sequencing  Graham Heimberg, Rajat.
Gene expression changes in damaged osteoarthritic cartilage identify a signature of non-chondrogenic and mechanical responses  S.L. Dunn, J. Soul, S.
Loyola Marymount University
Gene expression analysis
Transcriptional Signature of Histone Deacetylases in Breast cancer
Volume 172, Issue 1, Pages (January 2018)
Class Prediction Based on Gene Expression Data Issues in the Design and Analysis of Microarray Experiments Michael D. Radmacher, Ph.D. Biometric Research.
Angela L. Rasmussen, Michael G. Katze  Cell Host & Microbe 
Volume 5, Issue 6, Pages e3 (December 2017)
Florian T. Merkle, Kevin Eggan  Cell Stem Cell 
Figure 1 Experimental workflow and predictive modelling
Working with RNA-Seq Data
Volume 17, Issue 8, Pages (November 2016)
Volume 14, Issue 7, Pages (February 2016)
Pierre P. Massion, MD, Richard M. Caprioli, PhD 
Volume 9, Pages (November 2018)
Single Sample Expression-Anchored Mechanisms Predict Survival in Head and Neck Cancer Yang et al Presented by Yves A. Lussier MD PhD The University.
Cancer Stem Cells: Current Status and Evolving Complexities
Utilizing NGS-Data to Evaluate Anti-PD-1 Treatment
Inferring Tumor Phylogenies from Multi-region Sequencing
Loyola Marymount University
Label propagation algorithm
Integrative analysis of 111 reference human epigenomes
Loyola Marymount University
Figure 1. Identification of three tumour molecular subtypes in CIT and TCGA cohorts. We used CIT multi-omics data ( Figure 1. Identification of.
Loyola Marymount University
CD4+CLA+CD103+ T cells from human blood and skin share a transcriptional profile. CD4+CLA+CD103+ T cells from human blood and skin share a transcriptional.
Loyola Marymount University
BATLAS: Deconvoluting Brown Adipose Tissue
Gene expression profiles of T cells.
Defining the eTME genes.
Volume 28, Issue 3, Pages e7 (July 2019)
Global analysis of the chemical–genetic interaction map.
Presentation transcript:

High-throughput genomic profiling of tumor-infiltrating leukocytes Presented by: Bryan Shaw

Background TIL are a part of tumors and are well know to have major roles in cancer biology TIL are vital in tumor growth, cancer progression and response to therapy.

Figure 1. Current and emerging techniques for evaluating TIL composition in solid tumors. Aaron M Newman, Ash A Alizadeh High-throughput genomic profiling of tumor-infiltrating leukocytes Current Opinion in Immunology, Volume 41, 2016, 77–84 http://dx.doi.org/10.1016/j.coi.2016.06.006

In silico approaches for TIL profiling Enrichment measures for genes associated with individual cell types Leukocyte have established markers for FACS(Fluorescence-activated cell sorting) or IHC (immunohistochemistry) Algorithmic deconvolution of admixed transcriptomes to resolve composition Generating GEP (gene expression profiles) Derive additional marker genes using in silico nanodissection, a novel machine learning technique for predicting cell type-specific genes from GEP mixture data 

Class Method Input: Marker genes Input: Signature matrix Output: Gene enrichment Output: Cell type proportions Robust to >50% unknown content? Robust to random noise or multi-cell type perturbation? Marker gene expression obtained from mixture samples? Resolution of closely related cell types? Significance analysis for gene enrichment or cell type proportions? Enrichment methods Cluster analysis NA ND N TIL meta-genes Y SPEC ssGSEA Deconvolution methods DSA MMAD CIBERSORT LLSR PERT QP

Marker gene enrichment Using gene clusters is not useful for assigning marker genes as they are sensitive to noise Gene enrichment is not good for discriminating cell subsets but is good for inferring there are some Single Sample Gene Set Enrichment Analysis uses preranked GSEA to analyze gene sets

Gene expression deconvolution Gene expression deconvolution is an emerging technique analogous to in silico flow cytometry The deconvolution methods aim to computationally resolve a GEP into its component cell types (virtual tissue dissection) Expression Deconvolution Requires a signature matrix consisting of marker genes and their expression values Also requires a biological mixture There is also a vector which contains the cell subset of the mixture in the signature matrix m = G x f

Gene expression deconvolution These methods designed to analyze peripheral blood Abbas et al created an iterative least squares approach solving for f with a new signature matrix creation strategy Gong expanded on this work using quadratic programming Using non-negative constraints (cell fractions >0) able to demonstrate advantages of this method

Cell deconvolution for solid tumors Tumors are heterogeneous mixtures of cell types Very challenging requires deconvo methods to be extremely robust due to unknown cell types Digital Sorting Algorithm helped to reduce biological noise infer the expression levels of user-specified marker genes directly from RNA mixture samples Similar cell types are able to be given coefficients and grouped together to more accurately reflect their proportions in sample

Cell deconvolution for solid tumors Using CIBERSORT to enumarate cell proportions based on vector regression Uses linear loss function and L2-norm regulation making it robust to micture content , noise, and highly correlated cell subsets CIBERSORT was able to reveal complex associations between 22 leukocytes subsets from a GEP of 25 tumor types and thousands of tumor samples

Calibration of in silico TIL profiling methods Establish baseline performance, use marker genes (and signature matrices) be validated by analyzing independently generated GEPs the same leukocyte phenotypes different leukocyte phenotypes samples devoid of immune content Deconvolution methods should be robust by resolving all cell types within a given signature matrix; if external datasets are not available, this can be accomplished by leave-one-out cross validation Comparisons against flow cytometry, expression profiling performed on RNA to avoid alterations in cellular representation

Outstanding issues Maximum phenotype distinction is open Results depend on Features of the selected algorithm Robustness of the marker genes Level of unknown content and/or noise Expression profiling platform all methods are expected to benefit from the lower noise levels and increased dynamic range of RNA-seq

Outlook “In silico tissue dissection is an emerging class of techniques for large- scale characterization of tumor cellular heterogeneity…When integrated with complementary data, including somatic and epigenetic alterations, B-cell and T-cell receptor profiles, and imaging, in silico tissue dissection will lead to more comprehensive portraits of human tumors. In the near future, we expect such analyses to transform cancer therapy and management.”